BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25972506)

  • 1. Formulating the Future Research Agenda for Postexposure Prophylaxis for HIV: Methodological Challenges and Potential Approaches.
    Siegfried N; Beanland RL; Ford N; Mayer KH
    Clin Infect Dis; 2015 Jun; 60 Suppl 3():S205-11. PubMed ID: 25972506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. World Health Organization Guidelines on Postexposure Prophylaxis for HIV: Recommendations for a Public Health Approach.
    Ford N; Mayer KH;
    Clin Infect Dis; 2015 Jun; 60 Suppl 3():S161-4. PubMed ID: 25972497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choice of antiretroviral drugs for postexposure prophylaxis for adults and adolescents: a systematic review.
    Ford N; Shubber Z; Calmy A; Irvine C; Rapparini C; Ajose O; Beanland RL; Vitoria M; Doherty M; Mayer KH
    Clin Infect Dis; 2015 Jun; 60 Suppl 3():S170-6. PubMed ID: 25972499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Transition From Postexposure Prophylaxis to Preexposure Prophylaxis: An Emerging Opportunity for Biobehavioral HIV Prevention.
    Jain S; Krakower DS; Mayer KH
    Clin Infect Dis; 2015 Jun; 60 Suppl 3(Suppl 3):S200-4. PubMed ID: 25972505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis.
    Kuhar DT; Henderson DK; Struble KA; Heneine W; Thomas V; Cheever LW; Gomaa A; Panlilio AL;
    Infect Control Hosp Epidemiol; 2013 Sep; 34(9):875-92. PubMed ID: 23917901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. End Users' Views and Preferences on Prescribing and Taking Postexposure Prophylaxis for Prevention of HIV: Methods to Support World Health Organization Guideline Development.
    Beanland RL; Irvine CM; Green K
    Clin Infect Dis; 2015 Jun; 60 Suppl 3():S191-5. PubMed ID: 25972503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of human immunodeficiency virus and AIDS: postexposure prophylaxis (including health care workers).
    Beekmann SE; Henderson DK
    Infect Dis Clin North Am; 2014 Dec; 28(4):601-13. PubMed ID: 25287589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Starter packs versus full prescription of antiretroviral drugs for postexposure prophylaxis: a systematic review.
    Ford N; Venter F; Irvine C; Beanland RL; Shubber Z
    Clin Infect Dis; 2015 Jun; 60 Suppl 3():S182-6. PubMed ID: 25972501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Strategic Use of Antiretrovirals to Prevent HIV Infection: A Converging Agenda.
    Baggaley R; Doherty M; Ball A; Ford N; Hirnschall G
    Clin Infect Dis; 2015 Jun; 60 Suppl 3():S159-60. PubMed ID: 25972496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing adherence to preexposure and postexposure prophylaxis: the need for an integrated biobehavioral approach.
    Blashill AJ; Ehlinger PP; Mayer KH; Safren SA
    Clin Infect Dis; 2015 Jun; 60 Suppl 3(Suppl 3):S187-90. PubMed ID: 25972502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-Tablet Emtricitabine-Rilpivirine-Tenofovir as HIV Postexposure Prophylaxis in Men Who Have Sex With Men.
    Foster R; McAllister J; Read TR; Pierce AB; Richardson R; McNulty A; Carr A
    Clin Infect Dis; 2015 Oct; 61(8):1336-41. PubMed ID: 26123937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis.
    U.S. Public Health Service
    MMWR Recomm Rep; 2001 Jun; 50(RR-11):1-52. PubMed ID: 11442229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus postexposure prophylaxis for adolescents and children.
    Merchant RC; Keshavarz R
    Pediatrics; 2001 Aug; 108(2):E38. PubMed ID: 11483848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Australian gay men who have taken nonoccupational postexposure prophylaxis for HIV are in need of effective HIV prevention methods.
    Zablotska IB; Prestage G; Holt M; Poynten M; de Wit J; Guy R; Mao L; McAllister J; Grulich AE
    J Acquir Immune Defic Syndr; 2011 Dec; 58(4):424-8. PubMed ID: 21857349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Choice of antiretroviral drugs for postexposure prophylaxis for children: a systematic review.
    Penazzato M; Dominguez K; Cotton M; Barlow-Mosha L; Ford N
    Clin Infect Dis; 2015 Jun; 60 Suppl 3():S177-81. PubMed ID: 25972500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized controlled trial of the tolerability and completion of maraviroc compared with Kaletra® in combination with Truvada® for HIV post-exposure prophylaxis (MiPEP Trial).
    Milinkovic A; Benn P; Arenas-Pinto A; Brima N; Copas A; Clarke A; Fisher M; Schembri G; Hawkins D; Williams A; Gilson R;
    J Antimicrob Chemother; 2017 Jun; 72(6):1760-1768. PubMed ID: 28369381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal HIV Postexposure Prophylaxis Regimen Completion With Single Tablet Daily Elvitegravir/Cobicistat/Tenofovir Disoproxil Fumarate/Emtricitabine Compared With More Frequent Dosing Regimens.
    Mayer KH; Jones D; Oldenburg C; Jain S; Gelman M; Zaslow S; Grasso C; Mimiaga MJ
    J Acquir Immune Defic Syndr; 2017 Aug; 75(5):535-539. PubMed ID: 28696345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-exposure and postexposure prophylaxes and the combination HIV prevention methods (The Combine! Study): protocol for a pragmatic clinical trial at public healthcare clinics in Brazil.
    Grangeiro A; Couto MT; Peres MF; Luiz O; Zucchi EM; de Castilho EA; Estevam DL; Alencar R; Wolffenbüttel K; Escuder MM; Calazans G; Ferraz D; Arruda É; Corrêa Mda G; Amaral FR; Santos JC; Alvarez VS; Kietzmann T
    BMJ Open; 2015 Aug; 5(8):e009021. PubMed ID: 26307622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience of healthcare workers taking postexposure prophylaxis after occupational HIV exposures: findings of the HIV Postexposure Prophylaxis Registry.
    Wang SA; Panlilio AL; Doi PA; White AD; Stek M; Saah A
    Infect Control Hosp Epidemiol; 2000 Dec; 21(12):780-5. PubMed ID: 11140914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postexposure prophylaxis against human immunodeficiency virus.
    Tolle MA; Schwarzwald HL
    Am Fam Physician; 2010 Jul; 82(2):161-6. PubMed ID: 20642270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.